MRGPRX2 and Alzheimer disease: The novel small molecule MRGPRX2 antagonist GE1111 significantly restored macrophage phagocytotic activity, which can protect the skin from the Staphylococcus aureus colonisation characteristic of AD and AD pathophysiology (58).